The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
white-paper
BioPharma Due Diligence in a Shifting Global Market
Read More
post
The Startup’s Guide: 10 Must-Have CMC SOPs for Virtual Pharma in Phase 1
Read More
white-paper
The CMC Trap: How Chemistry, Manufacturing, and Controls Failures Derail Drug Development
Read More
post
FDA PreCheck Pilot: A Smarter, Infrastructure-Centered Alternative to Fast Track and Breakthrough Designations
Read More
Let's move from science to success.
Let’s Talk